BBPvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with BBP, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/26/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP ETF 2 | -2.65%– | +5.62%– | +28.37%– | +38.01%– | +119.28%– | +100.33%– |
| Flows | BBP ETF 2 | -– | +$26M– | +$66M– | +$78M– | +$83M– | +$76M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP ETF 2 | +28.32%– | +26.44%– | +24.98%– | +26.86%– |
| Max drawdown | BBP ETF 2 | -8.70%– | -9.59%– | -25.54%– | -37.61%– |
| Max drawdown duration | BBP ETF 2 | 68d– | 48d– | 292d– | 586d– |
Trading data
BBP | ETF 2 | |
Last sale 10/27/2026 at 1:30 PM | $104.89 | – |
| Previous close 10/26/2026 | $102.33 | – |
| Consolidated volume 10/26/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBP | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/27/2026 at 1:30 PM
Live
Closed
BBP | ETF 2 | |
|---|---|---|
| Last price | $104.89 | – |
| 1D performance | +2.50% | – |
| AuM | $127.99 M | – |
| E/R | 0.34% | – |
Characteristics
BBP | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | VIRTUS Investment Partners | – |
| Benchmark | LifeSci Biotechnology Products Index | – |
| N° of holdings | 66 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
BBP
USA
85.98%
Other
14.02%
ETF 2
Sectors
BBP
Healthcare
98.44%
Other
1.56%
ETF 2
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
31.08%
ETF 2
–
Top 15 holdings
Data as of August 31, 2026
BBP
Moderna, Inc.
3.58%
Crinetics Pharmaceuticals, Inc.
2.94%
Omeros Corp.
2.49%
Iovance Biotherapeutics, Inc.
2.36%
Verastem, Inc.
2.15%
Precigen, Inc.
1.99%
Halozyme Therapeutics, Inc.
1.84%
Zai Lab Ltd.
1.82%
Kiniksa Pharmaceuticals International Plc
1.81%
Kura Oncology, Inc.
1.72%
BeOne Medicines Ltd.
1.70%
Rigel Pharmaceuticals, Inc.
1.69%
Nuvation Bio, Inc.
1.69%
ACADIA Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
